• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 8300AB
Device Problems Perivalvular Leak (1457); Detachment of Device or Device Component (2907)
Patient Problems Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
Event Date 12/10/2022
Event Type  Injury  
Manufacturer Narrative
The subject device is not available for evaluation, as it remains implanted in the patient.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
It was reported that a patient with a 25mm 8300ab aortic valve, implanted for 4 years, 2 months, underwent a valve-in-valve procedure due to dehiscence.The patient was treated for a high-risk pci with impella support.During the attempt to place the impella, the wire and subsequently the impella were placed through the dehiscence rather than through the intuity.The pci was completed.When the position of the impella was realized, concern was noted that perhaps the frame of the intuity may have been bent by the impella.After the pci, the intuity was wired with a supportive wire, the impella was removed from the dehiscence, but severe pvl noted on echo.Attempts were made to dilate the intuity with a high pressure balloon to reduce the dehiscence and pvl.Unable to reduce the pvl by balloon dilation alone, the team deployed a 29mm 9600tfx valve within the intuity.The patient was sent to recovery in stable condition.
 
Manufacturer Narrative
The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Valve dehiscence may occur early or late.When it occurs in the early post-operative period, it is typically a result of an inadequate prosthetic valve implantation in combination with friable myocardial tissue.Late dehiscence can occur as a result of successive dilatation of cardiac structures that result from progression of disease.Valve dehiscence is not a malfunction of the device.Through further investigation, it was determined that the root cause of this event was most likely due to patient related factors.
 
Event Description
It was reported and learned through investigation that a patient with a 25mm 8300ab aortic valve, implanted for 4 years, 2 months, underwent a valve-in-valve procedure due to dehiscence and severe pvl.The patient presented with acute on chronic heart failure.The tavr procedure was completed successfully with a 29mm sapien 3 transcatheter valve.The patient was discharged from the hospital on pod# 8.The patient is s/p avr and cabg in 2018.He recently presented with chest discomfort and acute on chronic heart failure.Cardiac workup revealed severe pvl and severe cad.The patient underwent an impella supported pci.It was noted that the impella device was going through the pvl defect.Impella was removed and the patient was taken to the hybrid or to do an emergent tavr and pvl repair.The surgical valve was dilated via a 28mm true balloon and pvl improved to mild-moderate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INTUITY ELITE AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2- office m2013
irvine, CA 92614
9492506615
MDR Report Key16097136
MDR Text Key306643359
Report Number2015691-2023-09957
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194500
UDI-Public(01)00690103194500(17)220124
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/04/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/24/2022
Device Model Number8300AB
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/26/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Life Threatening;
Patient Age72 YR
Patient SexMale
-
-